参考文献/References:
[1] HE L,QU H,WU Q,et al.Lymphedema in survivors of breast cancer[J].Oncol Lett,2020,19(3):2085-2096.
[2] RIBEIRO PEREIRA A C P,KOIFMAN R J,BERGMAN A.Incidence and risk factors of lymphedema after breast cancer treatment:10 years of follow-up[J/OL].[2017-10-06].https://doi.org/10.1016/j.breast.2017.09.006.DOI:org/10.1016/j.breast.2017.09.006.
[3] THOMAS M.Breast cancer-related upper limb lymphoedema:an overview[J].Br J Community Nurs,2021,26(Suppl 4):S30-S35.
[4] BASTA M N,FOX J P,KANCHWALA S K,et al.Complicated breast cancer-related lymphedema:evaluating health care resource utilization and associated costs of management[J].Am J Surg,2016,211(1):133-141.
[5] JORGENSEN M G,TOYSERKANI N M,HANSEN F G,et al.The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment[J].NPJ Breast Cancer,2021,7(1):70-77.
[6] 臧荟然,毕晔,穆籣.乳腺癌术后上肢淋巴水肿的治疗与预防进展[J].中国修复重建外科杂志,2016,30(12):1567-1570.
[7] 史博慧,吕爱莉,王恋,等.乳腺癌术后上肢淋巴水肿预防策略的证据总结[J].护理学报,2020,27(22):32-38.
[8] 张蕊,郑黎强,潘国伟.疾病发病风险预测模型的应用与建立[J].中国卫生统计,2015,32(4):724-726.
[9] 李惠萍,杨娅娟,苏丹,等.不同预防行为对乳腺癌术后淋巴水肿的预防效果Meta分析[J].现代预防医学,2018,45(5):949-960.
[10]MOONS K G,DE GROOT J A,BOUWMEESTER W,et al.Critical appraisal and data extraction for systematic reviews of prediction modelling studies:the CHARMS checklist[J/OL].[2014-10-14].https://pubmed.ncbi.nlm.nih.gov/25314315/.DOI:10.1371/journal.pmed.1001744.
[11]MOONS K G M,WOLFF R F,RILEY R D,et al.PROBAST:a tool to assess risk of bias and applicability of prediction model studies:explanation and elaboration[J].Ann Intern Med,2019,170(1):W1-W33.
[12]BEVILACQUA J L B,KATTAN M W,YU C,et al.Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer[J].J Clin Oncol,2011,29(27):2580-9.
[13]BASTA M N,WU L C,KANCHWALA S K,et al.Reliable prediction of postmastectomy lymphedema:the risk assessment tool evaluating lymphedema[J].Am J Surg,2017,213(6):1125-1133.
[14]WANG L,LI H P,LIU A N,et al.A scoring system to predict arm lymphedema risk for individual chinese breast cancer patients[J].Breast Care,2016,11(1):52-56.
[15]GROSS J P,WHELAN T J,PARULEKAR W R,et al.Development and validation of a nomogram to predict lymphedema after axillary surgery and radiation therapy in women with breast cancer from the NCIC CTG MA.20 randomized trial[J].Int J Radiat Oncol Biol Phys,2019,105(1):165-173.
[16]KWAN J Y Y,FAMIYEH P,SU J,et al.Development and validation of a risk model for breast cancer-related lymphedema[J/OL].[2020-11-02].https://pubmed.ncbi.nlm.nih.gov/3317 5175/.DOI: 10.1001/jamanetworkopen.2020.24373.
[17]MARTíNEZ JAIMEZ P,ARMORA VERDU M,FORERO C G,et al.Breast cancer-related lymphoedema:risk factors and prediction model[J].J Adv Nurs,2021,78(3):765-775.
[18]LI X P,HUANG H,LIN Q M,et al.Validation of a breast cancer nomogram to predict lymphedema in a Chinese population[J].J Surg Res,2017(210):132-138.
相似文献/References:
[1]李星凤,李金花,李旭英,等.信息化技术在乳腺癌术后患者上肢功能康复中的应用进展[J].军事护理,2021,38(03):49.[doi:10.3969/j.issn.1008-9993.2021.03.012]
[2]蔡婷婷,黄青梅,袁长蓉.乳腺癌患者癌因性疲乏轨迹及其影响因素的研究进展[J].军事护理,2021,38(04):74.[doi:10.3969/j.issn.1008-9993.2021.04.019]
[3]刘卉,黄菊,刘娟.乳腺癌患者心理弹性量表的汉化及信效度检验[J].军事护理,2021,38(06):27.[doi:10.3969/j.issn.1008-9993.2021.06.007]
LIU Hui,HUANG Ju,LIU Juan.Reliability and Validity Test of the Chinese Version of Breast Cancer Survivors Resilience Scale[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(07):27.[doi:10.3969/j.issn.1008-9993.2021.06.007]
[4]刘玉瑶,张晓芳,魏洁丽,等.乳腺癌患者疾病接受度现状及影响因素的研究[J].军事护理,2021,38(12):38.[doi:10.3969/j.issn.1008-9993.2021.12.010]
LIU Yuyao,ZHANG Xiaofang,WEI Jieli,et al.Status Quo of Acceptance of Illness among Breast Cancer Patients and Its Influencing Factors[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(07):38.[doi:10.3969/j.issn.1008-9993.2021.12.010]
[5]彭艳婷,朱亚飞,马素慧,等.乳腺癌患者情绪抑制现状及其影响因素分析[J].军事护理,2022,39(03):40.[doi:10.3969/j.issn.1008-9993.2022.03.010]
PENG Yanting,ZHU Yafei,MA Suhui,et al.Status Quo of Emotional Inhibition among Patients with Breast Cancer and Its Influencing Factors[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(07):40.[doi:10.3969/j.issn.1008-9993.2022.03.010]
[6]李帆,黄莹,袁伟,等.延续护理信息平台对乳腺癌化疗患者自我管理能力和生存质量的影响研究[J].军事护理,2022,39(04):22.[doi:10.3969/j.issn.1008-9993.2022.04.006]
LI Fan,HUANG Ying,YUAN Wei,et al.Effect of Continuous Care Platform on Self-management Ability and Quality of Life of Breast Cancer Patients Undergoing Chemotherapy[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(07):22.[doi:10.3969/j.issn.1008-9993.2022.04.006]
[7]王金燕,杨瑒,朱凌曦,等.基于患者报告结局的乳腺癌患者社会功能的特征分析研究[J].军事护理,2022,39(07):21.[doi:10.3969/j.issn.2097-1826.2022.07.006]
WANG Jinyan,YANG Yang,ZHU Lingxi,et al.Characteristics of Social Functioning Among Breast Cancer Patients: An Analysis Based on Patient-Reported Outcomes[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(07):21.[doi:10.3969/j.issn.2097-1826.2022.07.006]
[8]阮君怡,刘城,况艺,等.年轻女性乳腺癌生存者经济毒性应对策略的质性研究[J].军事护理,2022,39(08):29.[doi:10.3969/j.issn.2097-1826.2022.08.008]
RUAN Junyi,LIU Cheng,KUANG Yi,et al.Coping Strategies for Financial Toxicity in Young Female Breast Cancer Survivors:A Qualitative Study[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(07):29.[doi:10.3969/j.issn.2097-1826.2022.08.008]
[9]王惠惠,李娜,李燕,等.社会支持对乳腺癌幸存者癌症复发恐惧的影响:心理复原力的中介效应[J].军事护理,2022,39(10):17.[doi:10.3969/j.issn.2097-1826.2022.10.005]
WANG Huihui,LI Na,LI Yan,et al.Influence of Social Support on the Fear of Cancer Recurrence in Breast Cancer Survivors:Mediating Effect of Psychological Resilience[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(07):17.[doi:10.3969/j.issn.2097-1826.2022.10.005]
[10]朱飞,路潜,刘春蕾,等.乳腺癌生育管理相关证据总结[J].军事护理,2022,39(11):81.[doi:10.3969/j.issn.2097-1826.2022.11.021]
ZHU Fei,LU Qian,LIU Chunlei,et al.Evidence Summary of Fertility Management for Breast Cancer Patients[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(07):81.[doi:10.3969/j.issn.2097-1826.2022.11.021]